Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

Clinical trial NCT00244634 · COMPLETED

Trial details

NCT number: NCT00244634
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pediatric Hypertension

Start date: 2003-09-01
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.